Metraipolis › archive › dc_01d793fca4fe

Neoadjuvant therapy combined with immunotherapy for anal sphincter preservation rate, clinical efficacy, and safety in rectal cancer patients: a meta-analysis — Europe PMC PMID:42630182

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42630182
DOI
10.3389/fonc.2026.1866026
License (as archived)
solo-consultazione
Archived
2026-10-16T23:22:34.447Z
SHA-256 of the archived text
e52c3636739ca17a79452f24652b9fc2ccf5773bb01e123074ab2271dc47c6b7
Stable URL of this page
https://metraipolis.com/documento/dc_01d793fca4fe

How to cite

Neoadjuvant therapy combined with immunotherapy for anal sphincter preservation rate, clinical efficacy, and safety in rectal cancer patients: a meta-analysis — Europe PMC PMID:42630182 — Europe PMC (en), https://europepmc.org/article/MED/42630182 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01d793fca4fe (Metraipolis archive dc_01d793fca4fe, sha256 e52c3636739ca17a79452f24652b9fc2ccf5773bb01e123074ab2271dc47c6b7)
BibTeX
@misc{dc01d793fca4fe,
  title = {Neoadjuvant therapy combined with immunotherapy for anal sphincter preservation rate, clinical efficacy, and safety in rectal cancer patients: a meta-analysis — Europe PMC PMID:42630182},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42630182},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01d793fca4fe; sha256 e52c3636739ca17a79452f24652b9fc2ccf5773bb01e123074ab2271dc47c6b7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42630182. Agents can read the archived copy with the MCP tool read_document.